Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7554/eLife.64139 http://scihub22266oqcxt.onion/10.7554/eLife.64139 33588991!7886324!33588991     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Elife 2021 ; 10 (ä): ä Nephropedia Template TP {{tp|p=33588991|t=2021. Antimicrobial resistance and COVID-19: Intersections and implications |pdf=|usr=}}{{33588991}} gab.com Text Antimicrobial resistance and COVID-19: Intersections and implications JO: Elife http://www.kidney.de/pget.php?&tw=1&pmid=33588991 #FOAvip Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analyse how changes due to COVID-19 in terms of antimicrobial usage, infection prevention, and health systems affect the emergence, transmission, and burden of AMR. Increased hand hygiene, decreased international travel, and decreased elective hospital procedures may reduce AMR pathogen selection and spread in the short term. However, the opposite effects may be seen if antibiotics are more widely used as standard healthcare pathways break down. Over 6 months into the COVID-19 pandemic, the dynamics of AMR remain uncertain. We call for the AMR community to keep a global perspective while designing finely tuned surveillance and research to continue to improve our preparedness and response to these intersecting public health challenges. Twit Text FOAVip Antimicrobial resistance and COVID-19: Intersections and implications ????Elife http://www.kidney.de/pget.php?&tw=1&pmid=33588991 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33588991 #FOAvip English Wikipedia <ref>{{Cite pmid|33588991}}</ref> Antimicrobial resistance and COVID-19: Intersections and implications #MMPMID33588991 Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI Elife 2021[Feb]; 10 (ä): ä PMID33588991show ga Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analyse how changes due to COVID-19 in terms of antimicrobial usage, infection prevention, and health systems affect the emergence, transmission, and burden of AMR. Increased hand hygiene, decreased international travel, and decreased elective hospital procedures may reduce AMR pathogen selection and spread in the short term. However, the opposite effects may be seen if antibiotics are more widely used as standard healthcare pathways break down. Over 6 months into the COVID-19 pandemic, the dynamics of AMR remain uncertain. We call for the AMR community to keep a global perspective while designing finely tuned surveillance and research to continue to improve our preparedness and response to these intersecting public health challenges. |*Anti-Bacterial Agents/supply & distribution/therapeutic use[MESH] |*COVID-19 Drug Treatment[MESH] |*COVID-19/epidemiology/prevention & control[MESH] |*Critical Pathways/organization & administration/trends[MESH] |Communicable Disease Control/methods/organization & administration[MESH] |Drug Resistance, Bacterial/*physiology[MESH] |Global Health/*trends[MESH] |Humans[MESH]Antimicrobial resistance and COVID-19: Intersections and implications (epmc).pdf DeepDyve Pubget Overpricing